Skip to main content
Caplight Logo









Haoyisheng

Haoyisheng

Private
BeijingHealthcare & Life Scienceshttps://haoyisheng.com/

Last Round

Private Equity

Sep 1, 2023

Total Funding Raised

$32.62M

Company Overview

Haoyisheng is a digital healthcare company that provides a comprehensive service platform for medical professionals, including continuing medical education, medical information, and online training resources.

Sector

Healthcare & Life Sciences

Verticals

Compliance, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

continuing medical educationCMEmedical certificationhealthcare compliancemedical trainingmed edvertical SaaSprofessional credit managementphysician trainingmedical licensureedtechB2B healthcareB2Ghealthcare workflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Haoyisheng Comparables

Compare Haoyisheng with similar companies based on industry and business-model similarity.

Haoyisheng comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Huayiwang Technology
92%
Beijing Billion and Bojia Education Technology Co., Ltd.
85%
Beijing Shuangwei Medical Technology Training Center
84%

Haoyisheng Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquitySep 1, 2023
Series AFeb 22, 2021

Key People

Founding team and executive leadership

Wang Hongbo

CTO

Executive Team

Haoyisheng Investors

Notable investors and investment history

Haoyisheng investors
InvestorRounds
OrbiMedSeries A
SBI HoldingsPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2023

    $17.1M round led by SBI Holdings.

  • Feb 22, 2021

    $16M round led by OrbiMed

Haoyisheng Filings

Explore SEC and related filing metadata, where available.

Haoyisheng filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Haoyisheng's valuation, stock price, and market status.

Is Haoyisheng a public or private company?

Haoyisheng is a private company.

What is the current stock price of Haoyisheng?

Haoyisheng is a private company with no public stock price. Caplight tracks Haoyisheng's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Haoyisheng worth (valuation)?

Valuation information for Haoyisheng is not publicly available.

Can I buy Haoyisheng stock?

Haoyisheng shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Haoyisheng's last funding round?

Haoyisheng's most recent funding round was Private Equity on September 1, 2023.

Who are the main investors in Haoyisheng?

Key investors in Haoyisheng include OrbiMed.

Will Haoyisheng IPO soon?

No public IPO plans have been announced for Haoyisheng.

How can I track Haoyisheng secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Haoyisheng's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range81
Year Founded2016
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?